213 related articles for article (PubMed ID: 3488951)
1. Anti-idiotypic antibodies to monoclonal antibody CO17-1A.
Herlyn D; Sears H; Iliopoulos D; Lubeck M; Douillard JY; Sindelar W; Tempero M; Mellstedt H; Maher M; Koprowski H
Hybridoma; 1986 Jul; 5 Suppl 1():S51-8. PubMed ID: 3488951
[TBL] [Abstract][Full Text] [Related]
2. Induction of specific immunity to human colon carcinoma by anti-idiotypic antibodies to monoclonal antibody CO17-1A.
Herlyn D; Ross AH; Iliopoulos D; Koprowski H
Eur J Immunol; 1987 Nov; 17(11):1649-52. PubMed ID: 3500066
[TBL] [Abstract][Full Text] [Related]
3. The human antimouse immunoglobulin response and the anti-idiotypic network have no influence on clinical outcome in patients with minimal residual colorectal cancer treated with monoclonal antibody CO17-1A.
Gruber R; van Haarlem LJ; Warnaar SO; Holz E; Riethmüller G
Cancer Res; 2000 Apr; 60(7):1921-6. PubMed ID: 10766181
[TBL] [Abstract][Full Text] [Related]
4. Phase I clinical trial of CO17-1A monoclonal antibody.
Lobuglio AF; Saleh M; Peterson L; Wheeler R; Carrano R; Huster W; Khazaeli MB
Hybridoma; 1986 Jul; 5 Suppl 1():S117-23. PubMed ID: 3488950
[TBL] [Abstract][Full Text] [Related]
5. Anti-idiotype cancer vaccines: pre-clinical and clinical studies.
Herlyn D; Benden A; Kane M; Somasundaram R; Zaloudik J; Sperlagh M; Marks G; Hart E; Ralph C; Wettendorff M
In Vivo; 1991; 5(6):615-23. PubMed ID: 1810448
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory activity of monoclonal anti-idiotypic antibody to anti-colorectal carcinoma antibody CO17-1A in animals and patients.
Herlyn D; Harris D; Zaloudik J; Sperlagh M; Maruyama H; Jacob L; Kieny MP; Scheck S; Somasundaram R; Hart E
J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):303-11. PubMed ID: 8061902
[TBL] [Abstract][Full Text] [Related]
7. Anti-idiotypic immunization provides protection against lethal endotoxaemia in BALB/c mice.
Cornelissen JJ; Maassen K; van Emst L; Weers PM; Harmsen M; Benaissa-Trouw BJ; Oosterlaken TA; Kraaijeveld CA; Verhoef J
Immunology; 1993 Aug; 79(4):673-80. PubMed ID: 8406595
[TBL] [Abstract][Full Text] [Related]
8. Anti-idiotype immunization of cancer patients: modulation of the immune response.
Herlyn D; Wettendorff M; Schmoll E; Iliopoulos D; Schedel I; Dreikhausen U; Raab R; Ross AH; Jaksche H; Scriba M
Proc Natl Acad Sci U S A; 1987 Nov; 84(22):8055-9. PubMed ID: 3500471
[TBL] [Abstract][Full Text] [Related]
9. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma.
Weiner LM; Moldofsky PJ; Gatenby RA; O'Dwyer J; O'Brien J; Litwin S; Comis RL
Cancer Res; 1988 May; 48(9):2568-73. PubMed ID: 3128400
[TBL] [Abstract][Full Text] [Related]
10. Patients treated with a monoclonal antibody (ab1) to the colorectal carcinoma antigen 17-1A develop a cellular response (DTH) to the "internal image of the antigen" (ab2).
Mellstedt H; Frödin JE; Biberfeld P; Fagerberg J; Giscombe R; Hernandez A; Masucci G; Li SL; Steinitz M
Int J Cancer; 1991 May; 48(3):344-9. PubMed ID: 2040527
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II (AII)-related idiotypic network. II. Heterogeneity and fine specificity of AII internal images analyzed with monoclonal antibodies.
Budisavljevic M; Geniteau-Legendre M; Baudouin B; Pontillon F; Verroust PJ; Ronco PM
J Immunol; 1988 May; 140(9):3059-65. PubMed ID: 2452197
[TBL] [Abstract][Full Text] [Related]
12. Human monoclonal anti-idiotypic antibodies. I. Establishment of immortalized cell lines from a tumor patient treated with mouse monoclonal antibodies.
Steinitz M; Tamir S; Frödin JE; Lefvert AK; Mellstedt H
J Immunol; 1988 Nov; 141(10):3516-22. PubMed ID: 2846688
[TBL] [Abstract][Full Text] [Related]
13. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
14. [The study of immunotherapy of ovarian carcinoma with anti-idiotypic antibody].
Wang J; Qian H; Feng J
Zhonghua Fu Chan Ke Za Zhi; 1996 Jun; 31(6):353-6. PubMed ID: 9206171
[TBL] [Abstract][Full Text] [Related]
15. Idiotypic cascades in cancer patients treated with monoclonal antibody CO17-1A.
Wettendorff M; Iliopoulos D; Tempero M; Kay D; DeFreitas E; Koprowski H; Herlyn D
Proc Natl Acad Sci U S A; 1989 May; 86(10):3787-91. PubMed ID: 2786203
[TBL] [Abstract][Full Text] [Related]
16. Detection of murine immunoglobulin in human tissues following therapeutic infusion of monoclonal antibody.
Ernst CS; Sears HF; Herlyn M; Herlyn D; Steplewski Z; Koprowski H
Hybridoma; 1986 Jul; 5 Suppl 1():S79-86. PubMed ID: 3527948
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal anti-idiotype antibody bearing the internal image of nasopharyngeal carcinoma associated antigen.
Li G; Hu J; Zhou G; Zhu J; Sun Q
Chin Med J (Engl); 2001 Sep; 114(9):962-6. PubMed ID: 11780392
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of the mouse monoclonal antibody 17-1A in cancer patients receiving various treatment schedules.
Frödin JE; Lefvert AK; Mellstedt H
Cancer Res; 1990 Aug; 50(16):4866-71. PubMed ID: 2379151
[TBL] [Abstract][Full Text] [Related]
19. Initial trial use of murine monoclonal antibodies as immunotherapeutic agents for gastrointestinal adenocarcinoma.
Sears HF; Herlyn D; Steplewski Z; Koprowski H
Hybridoma; 1986 Jul; 5 Suppl 1():S109-15. PubMed ID: 3488949
[No Abstract] [Full Text] [Related]
20. Induction of the immune response to Legionella pneumophila cytolysin by monoclonal anti-idiotypic antibodies.
Spitsin SV; Drobyshevskaya EI; Barkhatova OI; Belyi YF; Tartakovsky IS; Nesterenko VG
J Immunol; 1991 Sep; 147(6):2001-5. PubMed ID: 1890309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]